Radiant Innovation Inc. (TPEX:3373)
Taiwan · Delayed Price · Currency is TWD 17.95
+0.05 (0.28%)
Dec 29, 2025, 1:30 PM CST
Radiant Innovation Market Cap
Radiant Innovation has a market cap or net worth of 852.38 million as of December 26, 2025. Its market cap has decreased by -9.47% in one year.
Market Cap
852.38M
Enterprise Value
723.49M
Revenue
413.06M
Ranking
n/a
PE Ratio
n/a
Stock Price
17.95
Market Cap Chart
Since February 24, 2005, Radiant Innovation's market cap has increased from 300.96M to 852.38M, an increase of 183.22%. That is a compound annual growth rate of 5.12%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 26, 2025 | 852.38M | -14.39% |
| Dec 31, 2024 | 995.67M | -13.53% |
| Dec 29, 2023 | 1.15B | -5.67% |
| Dec 30, 2022 | 1.22B | -24.40% |
| Dec 30, 2021 | 1.61B | -55.22% |
| Dec 31, 2020 | 3.61B | 400.30% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Caliway Biopharmaceuticals | 250.47B |
| PharmaEssentia | 180.86B |
| Lotus Pharmaceutical | 73.24B |
| Heron Neutron Medical | 72.38B |
| Bora Pharmaceuticals Co., LTD. | 61.70B |
| Lin BioScience | 32.76B |
| Lumosa Therapeutics | 32.09B |
| Center Laboratories | 27.70B |